Market Exclusive

ABIOMED, Inc. (NASDAQ:ABMD) reported earnings of $0.82 per share beating Walls Streets expectations.

ABIOMED, Inc. (NASDAQ:ABMD) reported Q1 2018 earnings this Morning, coming in at $0.82 per share, beating Wall Street’s estimates of $0.42 per Share. Revenue for the quarter came in at $132.47 million beating analyst estimates of $130.83 million

Analyst Coverage For ABIOMED, Inc. (NASDAQ:ABMD)
These are 1 Hold Rating, 6 Buy Ratings .
The current consensus rating for ABIOMED, Inc. (NASDAQ:ABMD) is Buy (Score: 2.86) with a consensus target price of $150.00 , a potential (3.39% upside)Recent Insider Trading for ABIOMED, Inc. (NASDAQ:ABMD)

Recent Trading for ABIOMED, Inc. (NASDAQ:ABMD) Shares of ABIOMED, Inc. closed the previous trading session at 143.03 down -2.05 -1.41% with 731,352 shares trading hands.

Exit mobile version